{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T21:12:21Z","timestamp":1778879541072,"version":"3.51.4"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"am","delay-in-days":275,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020891","name":"Professional Staff Congress and City University of New York","doi-asserted-by":"publisher","award":["TRADB-49-271"],"award-info":[{"award-number":["TRADB-49-271"]}],"id":[{"id":"10.13039\/100020891","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01GM123508"],"award-info":[{"award-number":["R01GM123508"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["2U54MD017979-01A1"],"award-info":[{"award-number":["2U54MD017979-01A1"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ejphar.2025.177733","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T11:06:04Z","timestamp":1748430364000},"page":"177733","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["NOSH-aspirin (NBS-1120) attenuates motor defects and dopaminergic neuron degeneration in a rat model of Parkinson's disease"],"prefix":"10.1016","volume":"1002","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8737-7019","authenticated-orcid":false,"given":"Bita","family":"Firouzan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1394-6853","authenticated-orcid":false,"given":"Rasoul","family":"Ghasemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael T.","family":"Tetteh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7984-5396","authenticated-orcid":false,"given":"John B.","family":"Matson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4060-7283","authenticated-orcid":false,"given":"Khosrow","family":"Kashfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2025.177733_bib1","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nature20414","article-title":"Defects in trafficking bridge parkinson's disease pathology and genetics","volume":"539","author":"Abeliovich","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2025.177733_bib2","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s10571-015-0266-7","article-title":"Agmatine protects against 6-OHDA-Induced apoptosis, and ERK and Akt\/GSK disruption in SH-SY5Y cells","volume":"36","author":"Amiri","year":"2016","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2025.177733_bib3","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.2741\/e528","article-title":"The JNK signalling transduction pathway in the brain","volume":"4","author":"Antoniou","year":"2012","journal-title":"Front. Biosci.-Elite"},{"key":"10.1016\/j.ejphar.2025.177733_bib4","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jama.2019.22360","article-title":"Diagnosis and treatment of parkinson disease: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ejphar.2025.177733_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114147","article-title":"Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: a current perspective","volume":"180","author":"Bindu","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177733_bib6","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/j.1742-4658.2012.08491.x","article-title":"Animal models of parkinson's disease","volume":"279","author":"Blandini","year":"2012","journal-title":"FEBS J."},{"key":"10.1016\/j.ejphar.2025.177733_bib7","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0301-0082(01)00003-X","article-title":"Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in parkinson's disease","volume":"65","author":"Blum","year":"2001","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejphar.2025.177733_bib8","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.bbrc.2012.02.051","article-title":"NOSH-Aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid is a potent inhibitor of Colon cancer cell growth in vitro and in a xenograft mouse model","volume":"419","author":"Chattopadhyay","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2025.177733_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113857","article-title":"NOSH-Aspirin (NBS-1120) inhibits pancreatic cancer cell growth in a xenograft mouse model: modulation of FoxM1, p53, NF-\u03baB, iNOS, caspase-3 and ROS","volume":"176","author":"Chattopadhyay","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177733_bib10","doi-asserted-by":"crossref","DOI":"10.1124\/jpet.124.002240","article-title":"NOSH-Aspirin (NBS-1120) inhibits estrogen receptor-negative breast cancer in vitro and in vivo by modulating redox-sensitive signaling pathways","volume":"392","author":"Chattopadhyay","year":"2025","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2025.177733_bib11","doi-asserted-by":"crossref","first-page":"20451","DOI":"10.1074\/jbc.M311164200","article-title":"Phosphorylation of p38 MAPK induced by oxidative stress is linked to activation of both caspase-8-and-9-mediated apoptotic pathways in dopaminergic neurons","volume":"279","author":"Choi","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2025.177733_bib12","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/bies.10355","article-title":"Chronic activation of ERK and neurodegenerative diseases","volume":"25","author":"Colucci\u2010D'Amato","year":"2003","journal-title":"Bioessays"},{"key":"10.1016\/j.ejphar.2025.177733_bib13","article-title":"The role of p38 MAPK and its substrates in neuronal plasticity and neurodegenerative disease","volume":"2012","author":"Corr\u00eaa","year":"2012","journal-title":"J. Signal Trans."},{"key":"10.1016\/j.ejphar.2025.177733_bib14","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1007\/s12640-019-00151-6","article-title":"FGF21 protects dopaminergic neurons in parkinson's disease models via repression of neuroinflammation","volume":"37","author":"Fang","year":"2020","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.ejphar.2025.177733_bib15","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/0014-4886(69)90081-8","article-title":"Changes in dopamine levels in the corpus striatum following lesions in the substantia nigra","volume":"23","author":"Faull","year":"1969","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2025.177733_bib16","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.tins.2015.01.002","article-title":"Understanding opioid reward","volume":"38","author":"Fields","year":"2015","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ejphar.2025.177733_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056891","article-title":"Extracellular regulated kinase 1\/2 signaling is a critical regulator of interleukin-1\u03b2-mediated astrocyte tissue inhibitor of metalloproteinase-1 expression","volume":"8","author":"Fields","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2025.177733_bib18","first-page":"1210","article-title":"Inhibition of hydrogen sulfide generation contributes to gastric injury caused by anti-inflammatory nonsteroidal drugs","volume":"129","author":"Fiorucci","year":"2005","journal-title":"Gastroenterology (New York, N. Y., 1943)"},{"key":"10.1016\/j.ejphar.2025.177733_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2023.114585","article-title":"Dipeptide mimetic of BDNF ameliorates motor dysfunction and striatal apoptosis in 6-OHDA-induced Parkinson's rat model: considering akt and MAPKs signaling","volume":"452","author":"Firouzan","year":"2023","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2025.177733_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.133","article-title":"NOSH-Aspirin (NBS-1120), a dual nitric oxide and hydrogen sulfide-releasing hybrid, reduces inflammatory pain","volume":"3","author":"Fonseca","year":"2015","journal-title":"Pharmacol. Res. Perspect"},{"key":"10.1016\/j.ejphar.2025.177733_bib21","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.pbb.2004.04.022","article-title":"Sex dimorphisms in the neuroprotective effects of estrogen in an animal model of parkinson's disease","volume":"78","author":"Gillies","year":"2004","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2025.177733_bib22","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3233\/JAD-2011-110128","article-title":"A new hope for neurodegeneration: possible role of hydrogen sulfide","volume":"24","author":"Gong","year":"2011","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.ejphar.2025.177733_bib23","first-page":"G315","article-title":"Nitric oxide. I. Physiological chemistry of nitric oxide and its metabolites:implications in inflammation","volume":"276","author":"Grisham","year":"1999","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2025.177733_bib24","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.expneurol.2005.01.013","article-title":"Oxidative stress and inflammation in parkinson's disease: is there a causal link?","volume":"193","author":"Hald","year":"2005","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2025.177733_bib25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cardiores.2004.03.014","article-title":"NO suppresses while peroxynitrite sustains NF-\u03baB: a paradigm to rationalize cytoprotective and cytotoxic actions attributed to NO","volume":"63","author":"Hattori","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2025.177733_bib26","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/6137521","article-title":"Oxidative stress and neuroinflammation potentiate each other to promote progression of dopamine neurodegeneration","volume":"2020","author":"He","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ejphar.2025.177733_bib27","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","article-title":"Neuroinflammation in parkinson's disease: a target for neuroprotection?","volume":"8","author":"Hirsch","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejphar.2025.177733_bib28","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.4049\/jimmunol.151.7.3767","article-title":"Modulation of rat mast cell reactivity by IL-1 beta. Divergent effects on nitric oxide and platelet-activating factor release","volume":"151","author":"Hogaboam","year":"1993","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2025.177733_bib29","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1474-9726.2009.00543.x","article-title":"Neuroprotective effects of hydrogen sulfide on Parkinson's disease rat models","volume":"9","author":"Hu","year":"2010","journal-title":"Aging Cell"},{"key":"10.1016\/j.ejphar.2025.177733_bib30","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.1002\/(SICI)1521-4141(199812)28:12<4062::AID-IMMU4062>3.0.CO;2-K","article-title":"Nitric oxide regulates Th1 cell development through the inhibition of IL\u201012 synthesis by macrophages","volume":"28","author":"Huang","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ejphar.2025.177733_bib31","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/cns.13609","article-title":"Intranasal insulin improves mitochondrial function and attenuates motor deficits in a rat 6-OHDA model of parkinson's disease","volume":"27","author":"Iravanpour","year":"2021","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.ejphar.2025.177733_bib32","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1111\/j.1471-4159.2009.06112.x","article-title":"Activation of p38 MAPK in the substantia nigra leads to nuclear translocation of NF\u2010\u03baB in MPTP\u2010treated mice: implication in Parkinson's disease","volume":"109","author":"Karunakaran","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2025.177733_bib33","doi-asserted-by":"crossref","first-page":"12500","DOI":"10.1523\/JNEUROSCI.4511-08.2008","article-title":"Selective activation of p38 mitogen-activated protein kinase in dopaminergic neurons of substantia nigra leads to nuclear translocation of p53 in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-treated mice","volume":"28","author":"Karunakaran","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2025.177733_bib34","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1054-3589(08)57002-5","article-title":"Anti-inflammatory agents as cancer therapeutics","volume":"57","author":"Kashfi","year":"2009","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177733_bib35","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1089\/ars.2013.5308","article-title":"Anti-cancer activity of new designer hydrogen sulfide-donating hybrids","volume":"20","author":"Kashfi","year":"2014","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.ejphar.2025.177733_bib36","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.bcp.2012.10.019","article-title":"Biology and therapeutic potential of hydrogen sulfide and hydrogen sulfide-releasing chimeras","volume":"85","author":"Kashfi","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177733_bib37","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1089\/ars.2010.3671","article-title":"Inhaled hydrogen sulfide prevents neurodegeneration and movement disorder in a mouse model of parkinson's disease","volume":"15","author":"Kida","year":"2011","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.ejphar.2025.177733_bib38","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.bbadis.2009.12.009","article-title":"Pathological roles of MAPK signaling pathways in human diseases","volume":"1802","author":"Kim","year":"2010","journal-title":"Biochim. Biophys. Acta, Mol. Basis Dis."},{"key":"10.1016\/j.ejphar.2025.177733_bib39","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1096\/fj.04-1815fje","article-title":"Hydrogen sulfide protects neurons from oxidative stress","volume":"18","author":"Kimura","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2025.177733_bib40","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1021\/ml300002m","article-title":"NOSH-Aspirin: a novel nitric oxide-hydrogen sulfide-releasing hybrid: a new class of anti-inflammatory pharmaceuticals","volume":"3","author":"Kodela","year":"2012","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejphar.2025.177733_bib41","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.bcp.2015.09.014","article-title":"NOSH-Aspirin (NBS-1120), a novel nitric oxide-and hydrogen sulfide-releasing hybrid has enhanced chemo-preventive properties compared to aspirin, is gastrointestinal safe with all the classic therapeutic indications","volume":"98","author":"Kodela","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177733_bib42","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1046\/j.1471-4159.2001.00304.x","article-title":"Sustained extracellular signal\u2010regulated kinase activation by 6\u2010hydroxydopamine: implications for parkinson's disease","volume":"77","author":"Kulich","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2025.177733_bib43","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/0306-4522(95)00571-4","article-title":"Dopaminergic neuronal degeneration and motor impairments following axon terminal lesion by intrastriatal 6-hydroxydopamine in the rat","volume":"72","author":"Lee","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2025.177733_bib44","first-page":"1724","article-title":"NOSH-Aspirin (NBS-1120), a novel nitric oxide and hydrogen sulfide releasing hybrid, attenuates neuroinflammation induced by microglial and astrocytic activation: a new candidate for treatment of neurodegenerative disorders","volume":"61","author":"Lee","year":"2013","journal-title":"GLIA (New York, N. Y.)"},{"key":"10.1016\/j.ejphar.2025.177733_bib45","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.neurobiolaging.2009.06.001","article-title":"Astrocytes produce the antiinflammatory and neuroprotective agent hydrogen sulfide","volume":"30","author":"Lee","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ejphar.2025.177733_bib46","first-page":"103","article-title":"Hydrogen sulfide-releasing NSAIDs attenuate neuroinflammation induced by microglial and astrocytic activation","volume":"58","author":"Lee","year":"2010","journal-title":"GLIA (New York, N. Y.)"},{"key":"10.1016\/j.ejphar.2025.177733_bib47","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.3233\/JAD-2010-101002","article-title":"Hydrogen sulfide protects amyloid-\u03b2 induced cell toxicity in microglia","volume":"22","author":"Liu","year":"2010","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.ejphar.2025.177733_bib48","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s12264-017-0183-5","article-title":"Biomarkers for parkinson's disease: recent advancement","volume":"33","author":"Lotankar","year":"2017","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.ejphar.2025.177733_bib49","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.neuint.2018.11.005","article-title":"Behavioral tests predicting striatal dopamine level in a rat hemi-parkinson's disease model","volume":"122","author":"Miyanishi","year":"2019","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejphar.2025.177733_bib50","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s10571-006-9061-9","article-title":"Cellular and molecular mechanisms of parkinson's disease: neurotoxins, causative genes, and inflammatory cytokines","volume":"26","author":"Nagatsu","year":"2006","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2025.177733_bib51","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jlb.54.2.171","article-title":"Inflammation, immunoregulation, and inducible nitric oxide synthase","volume":"54","author":"Nussler","year":"1993","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.ejphar.2025.177733_bib52","first-page":"436","article-title":"Recurrent ischemic stroke: strategies for prevention","volume":"96","author":"Oza","year":"2017","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.ejphar.2025.177733_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/cells9071687","article-title":"Inflammation in parkinson's disease: mechanisms and therapeutic implications","volume":"9","author":"Pajares","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ejphar.2025.177733_bib54","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/labinvest.2009.124","article-title":"Small peptide inhibitor of JNKs protects against MPTP-Induced nigral dopaminergic injury via inhibiting the JNK-Signaling pathway","volume":"90","author":"Pan","year":"2010","journal-title":"Lab. Invest."},{"key":"10.1016\/j.ejphar.2025.177733_bib55","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1124\/mol.107.038463","article-title":"K252a prevents nigral dopaminergic cell death induced by 6-hydroxydopamine through inhibition of both mixed-lineage kinase 3\/c-Jun NH2-terminal kinase 3 (JNK3) and apoptosis-inducing kinase 1\/JNK3 signaling pathways","volume":"72","author":"Pan","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177733_bib56","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.neuint.2009.01.013","article-title":"Blockade of the translocation and activation of c-Jun N-terminal kinase 3 (JNK3) attenuates dopaminergic neuronal damage in mouse model of parkinson's disease","volume":"54","author":"Pan","year":"2009","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejphar.2025.177733_bib57","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/brain\/awh700","article-title":"Neuroprotection against ischaemic brain injury by a GluR6-9c peptide containing the TAT protein transduction sequence","volume":"129","author":"Pei","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.ejphar.2025.177733_bib58","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/bph.14110","article-title":"Achyranthes bidentata polypeptide protects dopaminergic neurons from apoptosis in parkinson's disease models both in vitro and in vivo","volume":"175","author":"Peng","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177733_bib59","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00281-013-0382-8","article-title":"Microglia and macrophages of the central nervous system: the contribution of microglia priming and systemic inflammation to chronic neurodegeneration","author":"Perry","year":"2013","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.ejphar.2025.177733_bib60","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11011-020-00636-w","article-title":"Current and emerging therapeutic targets for parkinson's disease","volume":"36","author":"Pingale","year":"2021","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.ejphar.2025.177733_bib61","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s12974-018-1236-z","article-title":"Inhibition of the hepatic Nlrp3 protects dopaminergic neurons via attenuating systemic inflammation in a MPTP\/p mouse model of parkinson's disease","volume":"15","author":"Qiao","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.ejphar.2025.177733_bib62","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s12640-019-0003-y","article-title":"The role of PI3K\/Akt and ERK in neurodegenerative disorders","volume":"35","author":"Rai","year":"2019","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.ejphar.2025.177733_bib63","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1126\/science.aag2590","article-title":"How neuroinflammation contributes to neurodegeneration","volume":"353","author":"Ransohoff","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2025.177733_bib64","first-page":"81s","article-title":"Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond","volume":"11","author":"Rao","year":"2008","journal-title":"J. Pharm. Pharmaceut. Sci."},{"key":"10.1016\/j.ejphar.2025.177733_bib65","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.lfs.2019.03.057","article-title":"Parkinson's disease: mechanisms, translational models and management strategies","volume":"226","author":"Raza","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2025.177733_bib66","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.919773","article-title":"Opioid receptor-mediated regulation of neurotransmission in the brain","volume":"15","author":"Reeves","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ejphar.2025.177733_bib67","article-title":"In vivo, in vitro and pharmacologic models of parkinson's disease","volume":"68","author":"Salari","year":"2019","journal-title":"Physiol. Res."},{"key":"10.1016\/j.ejphar.2025.177733_bib68","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF03033565","article-title":"The 6-hydroxydopamine model of parkinson's disease","volume":"11","author":"Simola","year":"2007","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.ejphar.2025.177733_bib69","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF03033565","article-title":"The 6-hydroxydopamine model of Parkinson's disease","volume":"11","author":"Simola","year":"2007","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.ejphar.2025.177733_bib70","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3121\/cmr.2020.1548","article-title":"Aspirin in primary prevention of cardiovascular events","volume":"18","author":"Soodi","year":"2020","journal-title":"Clin. Med. Res."},{"issue":"Suppl. 1","key":"10.1016\/j.ejphar.2025.177733_bib71","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/jnc.13691","article-title":"The clinical symptoms of parkinson's disease","volume":"139","author":"Sveinbjornsdottir","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2025.177733_bib72","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1046\/j.1365-2443.2002.00591.x","article-title":"Neuronal p38 MAPK signalling: an emerging regulator of cell fate and function in the nervous system","volume":"7","author":"Takeda","year":"2002","journal-title":"Genes Cells"},{"key":"10.1016\/j.ejphar.2025.177733_bib73","doi-asserted-by":"crossref","first-page":"114","DOI":"10.2174\/18756190MTA2pMjApy","article-title":"Role of nitric oxide in neurodegeneration: function, regulation, and inhibition","volume":"19","author":"Tewari","year":"2021","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ejphar.2025.177733_bib74","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1089\/ars.2014.5901","article-title":"Anti-inflammatory and cytoprotective actions of hydrogen sulfide: translation to therapeutics","volume":"22","author":"Wallace","year":"2015","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.ejphar.2025.177733_bib75","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1472-8206.2003.00125.x","article-title":"The therapeutic potential of NO-NSAIDs","volume":"17","author":"Wallace","year":"2003","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177733_bib76","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.pneurobio.2012.06.003","article-title":"Kinases and kinase signaling pathways: potential therapeutic targets in parkinson's disease","volume":"98","author":"Wang","year":"2012","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejphar.2025.177733_bib77","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1016\/j.febslet.2005.06.013","article-title":"PACAP protects neuronal differentiated PC12 cells against the neurotoxicity induced by a mitochondrial complex I inhibitor, rotenone","volume":"579","author":"Wang","year":"2005","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejphar.2025.177733_bib78","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jns.2009.06.034","article-title":"JNK inhibitor protects dopaminergic neurons by reducing COX-2 expression in the MPTP mouse model of subacute parkinson's disease","volume":"285","author":"Wang","year":"2009","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ejphar.2025.177733_bib79","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/sj.bjp.0707167","article-title":"Inflammation as a causative factor in the aetiology of parkinson's disease","volume":"150","author":"Whitton","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177733_bib80","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1126\/science.aax8814","article-title":"Neuroinflammation in the central nervous system: symphony of glial cells","volume":"67","author":"Yang","year":"2019","journal-title":"GLIA (New York, N. Y.)"},{"key":"10.1016\/j.ejphar.2025.177733_bib81","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2174\/187152411794961040","article-title":"p38 MAP kinase inhibitors as potential therapeutic drugs for neural diseases","volume":"11","author":"Yasuda","year":"2011","journal-title":"Cent. Nerv. Syst. Agents Med. Chem."},{"key":"10.1016\/j.ejphar.2025.177733_bib82","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21072605","article-title":"Anti-inflammatory drugs as anticancer agents","volume":"21","author":"Zappavigna","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.177733_bib83","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12974-021-02079-1","article-title":"Metabotropic glutamate receptor 5 inhibits \u03b1-synuclein-induced microglia inflammation to protect from neurotoxicity in parkinson's disease","volume":"18","author":"Zhang","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.ejphar.2025.177733_bib84","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1038\/s41418-018-0127-2","article-title":"Dopamine D2 receptor restricts astrocytic NLRP3 inflammasome activation via enhancing the interaction of \u03b2-arrestin2 and NLRP3","volume":"25","author":"Zhu","year":"2018","journal-title":"Cell Death Differ."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992500487X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992500487X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T20:26:01Z","timestamp":1778876761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429992500487X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":84,"alternative-id":["S001429992500487X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177733","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NOSH-aspirin (NBS-1120) attenuates motor defects and dopaminergic neuron degeneration in a rat model of Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177733","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"177733"}}